| Development of delayed-release proliposomes tablets for oral protein drug delivery. | |
| | |
MedLine Citation:
|
PMID: 21999514 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Context: One among many attempts to improve oral protein drug delivery was utilizing the colloidal drug carriers particularly liposomes. Objective: The purpose was to develop proliposomes of bovine serum albumin (BSA) in the form of granules and delayed-release tablets by using simple tablet manufacturing process. Materials and methods: BSA proliposomes granules were prepared by spraying 7:3 (w/w) - lecithin:cholesterol solution mixture onto BSA-mannitol granules rotating in a glass coating pan. BSA proliposomes granules were directly compressed into tablets and subsequently coated with Eudragit(®) L100 film. The physical properties and stability in gastrointestinal fluids of delayed-release BSA proliposomes tablets as well as reconstituted liposomes were assessed. Results: The BSA proliposomes tablets disintegrated readily and the obtained reconstituted BSA liposomes exhibited multilamellar vesicles, the size and entrapment efficiency of which were around 2-3 µm and 10-14%, respectively. The delayed-release BSA proliposomes tablets were found to be relatively stable in United States Pharmacopoeia (USP) simulated gastric and intestinal fluids. Increase in amount of BSA in granules resulted in the increase in entrapment efficiency and loading capacity. Discussion: The Fourier transform infrared spectroscopy (FTIR) results indicated increase in α-helix structure of BSA entrapped in liposomes. (31)P phosphorous nuclear magnetic resonance spectroscopy ((31)P-NMR) spectrum indicated interaction between BSA molecules and phosphoric acid polar groups of bilayers membrane. Conclusion: The delayed-release BSA proliposomes tablets developed could completely be reconstituted into liposomes with sufficient resistance to the hostile environment in gastrointestinal tract. |
| | |
Authors:
|
Charintra Tantisripreecha; Montree Jaturanpinyo; Busaba Panyarachun; Narong Sarisuta |
Related Documents
:
|
21871154 - Relative distribution of ketamine and norketamine in skeletal tissues following various... 7682804 - Reassessment of antithyroid drug therapy of graves' disease. 6733734 - Inotropic and vasodilator effects of amrinone on isolated human tissue. 22213594 - Assay validation of phosphorylated s6 ribosomal protein for a pharmacodynamic monitorin... 7752304 - Rabbit model for estimating relative bioavailability, residues and tissue tolerance of ... 18291644 - Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based and... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-15 |
Journal Detail:
|
Title: Drug development and industrial pharmacy Volume: - ISSN: 1520-5762 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7802620 Medline TA: Drug Dev Ind Pharm Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Manufacturing Pharmacy, Faculty of Pharmacy, Mahidol University , Bangkok , Thailand. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Growth independent rhamnolipid production from glucose using the non-pathogenic Pseudomonas putida K...
Next Document: Insights into the phosphoryl transfer mechanism of cyclin-dependent protein kinases from ab initio Q...